Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

[TREK1 potassium channels and depression].

Ye DQ, Zhang ZJ, Li Y.

Yao Xue Xue Bao. 2012 Nov;47(11):1403-8. Review. Chinese.

PMID:
23387069
2.

TREK1 channel blockade induces an antidepressant-like response synergizing with 5-HT1A receptor signaling.

Ye D, Li Y, Zhang X, Guo F, Geng L, Zhang Q, Zhang Z.

Eur Neuropsychopharmacol. 2015 Dec;25(12):2426-36. doi: 10.1016/j.euroneuro.2015.09.007. Epub 2015 Sep 25.

PMID:
26441141
3.

Protein complex analysis of native brain potassium channels by proteomics.

Sandoz G, Lesage F.

Methods Mol Biol. 2008;491:113-23. doi: 10.1007/978-1-59745-526-8_9.

PMID:
18998088
4.

The neuronal background K2P channels: focus on TREK1.

Honoré E.

Nat Rev Neurosci. 2007 Apr;8(4):251-61. Review.

PMID:
17375039
5.

Characterization of serotonin neurotransmission in knockout mice: implications for major depression.

Domínguez-López S, Howell R, Gobbi G.

Rev Neurosci. 2012;23(4):429-43. doi: 10.1515/revneuro-2012-0044. Review.

PMID:
23089640
6.

Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype.

Heurteaux C, Lucas G, Guy N, El Yacoubi M, Thümmler S, Peng XD, Noble F, Blondeau N, Widmann C, Borsotto M, Gobbi G, Vaugeois JM, Debonnel G, Lazdunski M.

Nat Neurosci. 2006 Sep;9(9):1134-41. Epub 2006 Aug 13.

PMID:
16906152
7.

Altered acetylcholine, bradykinin and cutaneous pressure-induced vasodilation in mice lacking the TREK1 potassium channel: the endothelial link.

Garry A, Fromy B, Blondeau N, Henrion D, Brau F, Gounon P, Guy N, Heurteaux C, Lazdunski M, Saumet JL.

EMBO Rep. 2007 Apr;8(4):354-9. Epub 2007 Mar 9.

8.

TREKing toward new antidepressants.

Gordon JA, Hen R.

Nat Neurosci. 2006 Sep;9(9):1081-3. No abstract available.

PMID:
16936765
9.

Extracellular acidification exerts opposite actions on TREK1 and TREK2 potassium channels via a single conserved histidine residue.

Sandoz G, Douguet D, Chatelain F, Lazdunski M, Lesage F.

Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14628-33. doi: 10.1073/pnas.0906267106. Epub 2009 Aug 10.

10.

5-HT7 receptor antagonists as a new class of antidepressants.

Mnie-Filali O, Lambás-Señas L, Zimmer L, Haddjeri N.

Drug News Perspect. 2007 Dec;20(10):613-8. doi: 10.1358/dnp.2007.20.10.1181354. Review.

PMID:
18301795
11.

Optical probing of a dynamic membrane interaction that regulates the TREK1 channel.

Sandoz G, Bell SC, Isacoff EY.

Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2605-10. doi: 10.1073/pnas.1015788108. Epub 2011 Jan 24.

12.

Enhancement of TREK1 channel surface expression by protein-protein interaction with beta-COP.

Kim E, Hwang EM, Yarishkin O, Yoo JC, Kim D, Park N, Cho M, Lee YS, Sun CH, Yi GS, Yoo J, Kang D, Han J, Hong SG, Park JY.

Biochem Biophys Res Commun. 2010 Apr 30;395(2):244-50. doi: 10.1016/j.bbrc.2010.03.171. Epub 2010 Apr 1.

PMID:
20362547
13.

Ischaemic concentrations of lactate increase TREK1 channel activity by interacting with a single histidine residue in the carboxy terminal domain.

Ghatak S, Banerjee A, Sikdar SK.

J Physiol. 2016 Jan 1;594(1):59-81. doi: 10.1113/JP270706. Epub 2015 Nov 17.

14.

5-HTTLPR genotype and gender, but not chronic fluoxetine administration, are associated with cortical TREK1 protein expression in rhesus macaques.

Bogdan R, Fitzgibbon H, Woolverton WL, Bethea CL, Iyo AH, Stockmeier CA, Kyle PB, Austin MC.

Neurosci Lett. 2011 Oct 3;503(2):83-6. doi: 10.1016/j.neulet.2011.08.005. Epub 2011 Aug 17.

15.

Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor.

Gardier AM.

Behav Pharmacol. 2009 Feb;20(1):18-32. doi: 10.1097/FBP.0b013e3283243fcd. Review.

PMID:
19179848
16.

Dominant negative effects of a non-conducting TREK1 splice variant expressed in brain.

Veale EL, Rees KA, Mathie A, Trapp S.

J Biol Chem. 2010 Sep 17;285(38):29295-304. doi: 10.1074/jbc.M110.108423. Epub 2010 Jul 6.

17.

Influence of the N terminus on the biophysical properties and pharmacology of TREK1 potassium channels.

Veale EL, Al-Moubarak E, Bajaria N, Omoto K, Cao L, Tucker SJ, Stevens EB, Mathie A.

Mol Pharmacol. 2014 May;85(5):671-81. doi: 10.1124/mol.113.091199. Epub 2014 Feb 7.

18.

Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters.

Haenisch B, Bönisch H.

Pharmacol Ther. 2011 Mar;129(3):352-68. doi: 10.1016/j.pharmthera.2010.12.002. Epub 2010 Dec 13. Review.

PMID:
21147164
19.

[TREK-1: a potential target for novel antidepressants].

Maruyama Y, Yamada M.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2007 Aug;27(4):147-51. Review. Japanese.

PMID:
17879592
20.

Pharmacogenetics of antidepressive drugs: a way towards personalized treatment of major depressive disorder.

Weizman S, Gonda X, Dome P, Faludi G.

Neuropsychopharmacol Hung. 2012 Jun;14(2):87-101. Review.

Supplemental Content

Support Center